Table 1.
Number (percent) of follow-up months in which the patient was in various states of SLE disease activity.
| State of Disease Activity | Number (percent) of follow-up months state (n=77,105) |
|---|---|
| LLDAS | 38,880 (50%) |
| Clinical Remission On Treatment1 | 20,489 (27%) |
| Clinical Remission with No Treatment2 | 10,347 (13%) |
1
Requires Prednisone dose ≤ 5 mg/day, but allows for maintenance immunosuppressants and hydroxychloroquine.
2
Requires no use of prednisone or immunosuppressants, but allows for use of hydroxychloroquine